Pulmonary fibrosis – Diagnostics

Go back

Pulmonary fibrosis is a lung condition where scarring develops in the tissue around the tiny air sacs, making breathing increasingly difficult. Identifying this disease early and accurately is crucial, as proper diagnosis allows healthcare teams to create treatment plans that may slow progression and improve quality of life. Understanding which tests are used to detect and monitor this condition helps patients and their families navigate the medical journey with greater confidence.

Introduction: When to Seek Diagnostic Evaluation

If you’ve been experiencing shortness of breath that doesn’t seem to improve, particularly during activities that once felt easy, it may be time to seek medical attention. Many people initially dismiss these symptoms as simply getting older or being out of shape, but persistent breathing difficulties warrant professional evaluation.[1] A dry cough that continues for more than three weeks is another important signal that should not be ignored.[13]

Pulmonary fibrosis often develops gradually, which means symptoms can be subtle at first. You might notice feeling unusually tired, losing weight without trying, or experiencing aching muscles and joints.[1] Some people also develop clubbing, which refers to widening and rounding of the fingertips or toes.[2] These symptoms occur because scarred lung tissue becomes thick and stiff, making it harder for oxygen to pass from the lungs into the bloodstream.

Anyone experiencing these warning signs should consult their primary care doctor. This is especially important for people who are 65 or older, those who smoke or have smoked in the past, individuals with repeated exposure to dusts or chemicals through work, or those with a family history of lung disease.[2] The earlier pulmonary fibrosis is identified, the more options healthcare teams have to help manage the condition and maintain quality of life.

⚠️ Important
Do not ignore persistent breathing problems or a cough lasting more than three weeks. While these symptoms can have many causes, early diagnosis of pulmonary fibrosis is essential for proper management. If your symptoms suddenly worsen over days or weeks, seek immediate medical attention, as this could indicate a serious complication requiring urgent care.[8]

Classic Diagnostic Methods

Medical History and Physical Examination

The diagnostic process begins with a thorough discussion between you and your healthcare provider. Your doctor will ask detailed questions about your symptoms, including when they started and how they have changed over time. They will want to know about your work history, particularly any exposure to dusts, gases, chemicals, or similar substances that could damage the lungs.[11] Family medical history is also important, as some forms of pulmonary fibrosis can run in families.[1]

During the physical exam, your doctor will listen carefully to your lungs with a stethoscope. Pulmonary fibrosis often produces a distinctive crackling sound at the base of the lungs when you breathe, sometimes described as similar to the sound of velcro being pulled apart.[11] Your doctor will also check for signs of clubbed fingers and may examine your skin for any bluish discoloration around the lips or fingernails, which can indicate low oxygen levels.[2]

Imaging Tests

Imaging tests create pictures of the inside of your lungs and are fundamental for diagnosing pulmonary fibrosis. A chest X-ray is often one of the first tests ordered. This test can show the scarred tissue characteristic of pulmonary fibrosis, although in early stages, the X-ray may appear normal even when lung damage is present.[11] When this happens, additional imaging is needed.

A high-resolution computed tomography (CT) scan is much more detailed than a regular chest X-ray. This test combines multiple X-ray images taken from different angles to create cross-sectional pictures of your lungs.[2] High-resolution CT scans are particularly helpful because they can reveal the extent of lung damage and identify specific patterns of scarring. Different types of pulmonary fibrosis create distinct patterns, which helps doctors narrow down the specific diagnosis.[11] The scan is painless and typically takes only a few minutes, though you need to lie still on a table that moves through a large, donut-shaped machine.

An echocardiogram may also be performed. This test uses sound waves to create moving pictures of your heart. While it examines the heart rather than the lungs directly, it provides important information about how pulmonary fibrosis affects the heart. Scarred lungs can increase pressure in the blood vessels of the lungs, which forces the heart to work harder. The echocardiogram measures this pressure and evaluates how well the heart is functioning.[11]

Pulmonary Function Tests

Pulmonary function tests, also called lung function tests, measure how well your lungs are working. These tests are essential for understanding the severity of lung damage and tracking changes over time.[2] One common test is spirometry, where you breathe out as quickly and forcefully as possible through a tube connected to a machine. The machine measures how much air your lungs can hold and how quickly you can exhale.[11]

Other pulmonary function tests might measure how well oxygen moves from your lungs into your bloodstream. This is important because even if the total amount of air you can breathe seems adequate, the scarred tissue may prevent oxygen from reaching your blood efficiently. The testing is non-invasive and usually takes less than an hour to complete.

Blood Tests

Blood tests help doctors understand your overall health and check for conditions that might be causing lung scarring. One specific blood test is the arterial blood gas, which measures the levels of oxygen and carbon dioxide in your blood.[2] This test requires drawing blood from an artery, usually in your wrist, and provides precise information about how well your lungs are transferring oxygen to your bloodstream.

Other blood tests may look for signs of autoimmune diseases, which are conditions where the body’s immune system attacks its own tissues. Autoimmune diseases such as rheumatoid arthritis, lupus, or scleroderma can cause pulmonary fibrosis.[2] Identifying these conditions is crucial because the treatment approach may differ from other types of pulmonary fibrosis.

Bronchoscopy and Biopsy

When imaging and other tests don’t provide enough information for a definitive diagnosis, your doctor may recommend a bronchoscopy. During this procedure, a thin, flexible tube with a tiny camera on the end is inserted through your nose or mouth and guided into your lungs.[2] This allows the doctor to see inside your airways and collect small samples of lung tissue or fluid for examination under a microscope.

A lung biopsy involves removing a small piece of lung tissue to examine it closely. Sometimes this is done during a bronchoscopy, but other times it may require a surgical procedure. While the idea of a biopsy can seem frightening, it provides the most detailed information about what is happening in your lungs. The tissue sample can reveal the specific pattern of scarring and help distinguish pulmonary fibrosis from other lung conditions that might look similar on scans.[8]

Distinguishing Pulmonary Fibrosis from Other Conditions

One of the challenges in diagnosing pulmonary fibrosis is that its symptoms overlap with many other respiratory conditions. Chronic obstructive pulmonary disease (COPD), asthma, and heart failure can all cause shortness of breath and coughing. The combination of tests described above helps doctors differentiate pulmonary fibrosis from these other possibilities.

When doctors cannot identify a specific cause for the lung scarring despite thorough testing, the condition is called idiopathic pulmonary fibrosis, with “idiopathic” meaning the cause is unknown. This is actually the most common form of pulmonary fibrosis.[2] Even without knowing the exact cause, doctors can still provide appropriate treatment and support based on the diagnosis.

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or approaches to managing pulmonary fibrosis. These studies have specific requirements for who can participate, and diagnostic tests play a crucial role in determining eligibility. Understanding these requirements can help you and your doctor decide whether participating in a clinical trial might be an option for you.

Standard Qualification Criteria

Clinical trials for pulmonary fibrosis typically require documented evidence of the disease through diagnostic testing. This usually means having a high-resolution CT scan that shows the characteristic patterns of lung scarring. The CT images must demonstrate findings consistent with pulmonary fibrosis rather than other lung conditions. Many trials specifically focus on idiopathic pulmonary fibrosis, so investigators need to confirm that no identifiable cause for the scarring can be found.

Pulmonary function tests are almost always required for trial enrollment. Researchers use these results to ensure that participants have lung function within a specific range. Some trials may only accept people with mild to moderate disease, while others might focus on more advanced cases. The tests measure parameters such as forced vital capacity (the total amount of air you can forcefully exhale after taking a deep breath), which gives researchers a baseline to compare against later in the study.

Blood tests confirming overall organ function, particularly kidney and liver function, are commonly required. This is because many experimental treatments are processed through these organs, and researchers need to ensure participants can safely metabolize the medications being studied. Blood tests also help identify any other medical conditions that might interfere with the study or make participation unsafe.

Specialized Diagnostic Requirements

Some clinical trials may require more specialized testing beyond the standard diagnostic workup. For example, certain studies investigating specific types of pulmonary fibrosis related to autoimmune diseases might require detailed immunological testing to confirm the presence of specific antibodies in your blood.

Genetic testing may be requested for trials studying familial forms of pulmonary fibrosis or investigating treatments that target specific genetic factors. These tests analyze your DNA to look for mutations known to be associated with the disease.[7] If you have family members with pulmonary fibrosis, this information becomes particularly relevant.

Exercise testing, such as a six-minute walk test, is often included in clinical trial screening. This simple test measures how far you can walk in six minutes and tracks changes in your oxygen levels and heart rate during the activity. It provides practical information about how the disease affects your daily function and gives researchers a way to measure whether treatments improve your ability to be active.

⚠️ Important
Not everyone with pulmonary fibrosis will qualify for clinical trials, and that’s perfectly normal. Trials have specific inclusion and exclusion criteria designed to ensure participant safety and study validity. If you’re interested in participating, discuss this with your medical team early in your diagnostic journey. They can help identify trials that might be appropriate for your specific situation and ensure all necessary diagnostic documentation is available.

Ongoing Monitoring During Trials

Once enrolled in a clinical trial, participants undergo regular diagnostic testing to monitor their response to treatment and ensure safety. This typically includes repeated pulmonary function tests, blood work, and imaging at scheduled intervals. These tests serve dual purposes: they help researchers evaluate whether the experimental treatment is working, and they allow medical teams to detect any potential side effects or complications early.

The frequency and type of monitoring varies depending on the specific trial, but participants generally receive more intensive medical oversight than they might in routine care. This comprehensive monitoring is one of the benefits of trial participation, as it provides detailed tracking of disease progression and overall health status.

Prognosis and Survival Rate

Prognosis

The course of pulmonary fibrosis varies significantly from person to person, making it difficult to predict exactly how the disease will progress in any individual. Some people remain relatively stable for many years with minimal change in symptoms, while others experience more rapid worsening of their condition.[1] The disease typically gets progressively worse over time, meaning lung function gradually declines and breathing becomes more difficult.[2]

Several factors can influence prognosis. Age at diagnosis plays a role, with idiopathic pulmonary fibrosis usually affecting people in their seventies. The extent of scarring visible on high-resolution CT scans at the time of diagnosis provides important information about disease severity. Results from pulmonary function tests, particularly measurements of how much air the lungs can hold and how efficiently oxygen transfers to the bloodstream, help doctors assess the current state of lung function and predict future decline.[14]

Regular monitoring through follow-up appointments and repeated testing helps healthcare teams understand whether the disease is progressing quickly or slowly in each individual. This information guides treatment decisions and helps patients and families plan for the future. Some people develop complications such as low oxygen levels requiring supplemental oxygen therapy, high blood pressure in the lung arteries (pulmonary hypertension), or increased risk of lung infections, which can affect overall prognosis.[2]

Survival Rate

Life expectancy with pulmonary fibrosis depends on multiple factors including the type of pulmonary fibrosis, how advanced it is at diagnosis, overall health, and response to treatment. For idiopathic pulmonary fibrosis specifically, life expectancy is generally less than five years from the time of diagnosis.[7] However, this is an average, and individual experiences vary considerably. Some people live much longer, especially with appropriate treatment and medical management.

The progression of idiopathic pulmonary fibrosis is typically measured over a period of three to five years from diagnosis.[16] Newer antifibrotic medications such as pirfenidone and nintedanib have been shown to slow the decline in lung function, which may improve survival and quality of life for people with this condition. Access to specialized care at centers experienced in treating pulmonary fibrosis can also positively influence outcomes.

For some patients, lung transplantation represents an option that can extend life expectancy. This major surgical procedure is carefully considered based on age, overall health, disease severity, and other factors. Lung transplantation is the only treatment currently shown to increase life expectancy in pulmonary fibrosis.[16] However, not everyone is a candidate for transplant, and the decision involves weighing many complex medical and personal considerations with the healthcare team.

Ongoing Clinical Trials on Pulmonary fibrosis

  • Long-Term Safety Study of Inhaled Pirfenidone for Patients with Progressive or Idiopathic Pulmonary Fibrosis

    Recruiting

    1 1
    Investigated drugs:
    Czechia France Germany Italy The Netherlands Poland +1
  • Study on the Effects of Inhaled Treprostinil for Patients with Progressive Pulmonary Fibrosis

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy Spain
  • Study of Inhaled Pirfenidone for Patients with Progressive Pulmonary Fibrosis

    Recruiting

    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Poland +1
  • A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

    Not yet recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Denmark Finland France +9
  • Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

    Not recruiting

    Investigated drugs:
    Austria Belgium Czechia Denmark Finland France +9

References

https://www.mayoclinic.org/diseases-conditions/pulmonary-fibrosis/symptoms-causes/syc-20353690

https://my.clevelandclinic.org/health/diseases/10959-pulmonary-fibrosis

https://www.pulmonaryfibrosis.org/understanding-pff/about-pulmonary-fibrosis/what-is-pulmonary-fibrosis

https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-fibrosis/introduction

https://pmc.ncbi.nlm.nih.gov/articles/PMC2675823/

https://www.actionpf.org/information-support/what-is-pulmonary-fibrosis

https://en.wikipedia.org/wiki/Pulmonary_fibrosis

https://www.healthdirect.gov.au/pulmonary-fibrosis

https://www.tgh.org/institutes-and-services/conditions/pulmonary-fibrosis

https://www.pulmonaryfibrosis.org/patients-caregivers/education-resources/fact-sheets

https://www.mayoclinic.org/diseases-conditions/pulmonary-fibrosis/diagnosis-treatment/drc-20353695

https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-fibrosis/patients/how-is-pulmonary-fibrosis-treated

https://www.nhs.uk/conditions/idiopathic-pulmonary-fibrosis/

https://my.clevelandclinic.org/health/diseases/10959-pulmonary-fibrosis

https://www.pulmonaryfibrosis.org/understanding-pff/treatment-options/medications

https://pmc.ncbi.nlm.nih.gov/articles/PMC9060042/

https://medicine.yale.edu/news-article/advancing-therapies-for-pulmonary-fibrosis/

https://uvahealth.com/conditions/pulmonary-fibrosis

https://www.pulmonaryfibrosis.org/patients-caregivers/education-resources/maintain-your-health

https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-fibrosis/patients/living-well-with-pulmonary-fibrosis/living-with-pulmonary

https://pfwarriors.com/5-secrets-from-patients-living-with-pulmonary-fibrosis/

https://www.nhlbi.nih.gov/health/idiopathic-pulmonary-fibrosis/living-with

https://www.actionpf.org/information-support/eating-well-with-pulmonary-fibrosis

https://lungfoundation.com.au/articles/five-tips-to-manage-pulmonary-fibrosis/

https://www.mayoclinic.org/diseases-conditions/pulmonary-fibrosis/diagnosis-treatment/drc-20353695

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

How long does it take to diagnose pulmonary fibrosis?

The diagnostic process varies for each person but often takes several weeks to months. Many people are not diagnosed until they have been living with symptoms for some time, as early symptoms can be subtle and easily mistaken for aging or other conditions.[1] The process involves multiple tests including imaging, pulmonary function tests, and possibly a biopsy, each requiring separate appointments. Finding an accurate diagnosis is worth the time, as it ensures appropriate treatment.

Do I need a lung biopsy to diagnose pulmonary fibrosis?

Not everyone needs a lung biopsy. Many cases can be diagnosed through a combination of medical history, physical examination, high-resolution CT scans, and pulmonary function tests.[11] However, when imaging and other tests don’t provide enough information to make a definitive diagnosis, or when doctors need to distinguish between different types of lung disease, a biopsy may be recommended to examine lung tissue directly under a microscope.[8]

Can pulmonary fibrosis be detected on a regular chest X-ray?

A chest X-ray can sometimes show scarring associated with pulmonary fibrosis, but it’s not always reliable, especially in early stages of the disease. The X-ray may appear completely normal even when lung damage is present.[11] This is why doctors often order additional tests, particularly a high-resolution CT scan, which provides much more detailed images and is better at detecting lung scarring.

What is the difference between idiopathic pulmonary fibrosis and other types of pulmonary fibrosis?

Idiopathic pulmonary fibrosis means the cause of lung scarring is unknown, even after thorough testing. It is the most common form of pulmonary fibrosis.[2] Other types have identifiable causes such as autoimmune diseases, environmental exposures to dusts or chemicals, certain medications, or radiation therapy. Determining whether pulmonary fibrosis is idiopathic or has a known cause is important because it can affect treatment approaches and prognosis.

Will I need repeated testing after diagnosis?

Yes, regular follow-up testing is an important part of managing pulmonary fibrosis. Your healthcare team will monitor disease progression and treatment response through repeated pulmonary function tests, imaging studies, and blood work.[22] The frequency of these tests depends on your individual situation, but monitoring helps your medical team adjust treatments as needed and identify any complications early. Regular checkups also allow you to discuss any changes in symptoms or concerns about your condition.

🎯 Key Takeaways

  • Don’t ignore persistent shortness of breath or a cough lasting more than three weeks—these symptoms warrant medical evaluation, especially if you’re over 65, have smoked, or work with dusts or chemicals
  • Diagnosis requires multiple tests working together like pieces of a puzzle, including imaging, breathing tests, and blood work, rather than relying on just one examination
  • A high-resolution CT scan reveals detailed patterns of lung scarring that help distinguish pulmonary fibrosis from more than 200 other interstitial lung diseases
  • The distinctive crackling sound pulmonary fibrosis makes in the lungs—like velcro pulling apart—can be heard with a stethoscope during a physical exam
  • When no cause for lung scarring can be identified after thorough testing, it’s called idiopathic pulmonary fibrosis, which is actually the most common form of the disease
  • Clinical trials have specific diagnostic requirements and often provide more intensive monitoring than routine care, offering both access to new treatments and detailed health tracking
  • Early diagnosis matters because treatments like antifibrotic medications work best when started before extensive lung damage occurs
  • Regular follow-up testing after diagnosis helps medical teams track whether the disease is progressing quickly or slowly in your individual case, guiding personalized treatment decisions